This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

PG63(A) Guideline for safe care for patients sedated in health care facilities for acute behavioural disturbance